← FDA Drug Approvals (Drugs@FDA)
NAPROXEN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2011-08-24
Drug application
- FDA Application #
ANDA091305- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN
- Generic name
- NAPROXEN
- Active ingredients
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- INVAGEN PHARMS
- Manufacturer
- Exelan Pharmaceuticals, Inc.
- First approval
- 2011-08-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown